Concepedia

Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.

Antonio Tursi, Giovanni Brandimarte, Gian Marco Giorgetti, Giacomo Forti, Maria Ester Modeo, Andrea Gigliobianco

PubMed · 2004 · 241 citations · 22 references

Abstract

Balsalazide/VSL#3 may be a very good choice in the treatment of active mild-to-moderate active ulcerative colitis instead of balsalazide alone or mesalazine.

References

22

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial

Paolo Gionchetti, Fernando Rizzello, Alessandro Venturi et al. · Gastroenterology · 2000 · 1.5K citations

, , +6

Double‐blind comparison of an oral <i>Escherichia coli</i> preparation and mesalazine in maintaining remission of ulcerative colitis

Wolfgang Kruis, E. SCHÜTZ, P Frič et al. · Alimentary Pharmacology & Therapeutics · 1997 · 763 citations

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis

Venturi, Paolo Gionchetti, Fernando Rizzello et al. · Alimentary Pharmacology & Therapeutics · 1999 · 563 citations

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG

Cosimo Prantera · Gut · 2002 · 561 citations · Full text

THE ROLE OF INTESTINAL BACTERIA IN THE METABOLISM OF SALICYLAZOSULFAPYRIDINE

Mark A. Peppercorn, Peter Goldman · Journal of Pharmacology and Experimental Therapeutics · 1972 · 435 citations